IDEAYA Biosciences (IDYA) Treasury Shares (2018 - 2019)
IDEAYA Biosciences (IDYA) posted Treasury Shares of $7313.0 for Q3 2021, little changed sequentially from $7313.0 in Q2 2021, and down 50.0% YoY from $14625.0 in Q3 2020.
Analysis
IDEAYA Biosciences (IDYA) Treasury Shares (2018 - 2019) Analysis & Trends
IDEAYA Biosciences has reported Treasury Shares for 4 years, with the latest figure at $7313.0 in Q3 2021.
- Quarterly Treasury Shares fell 50.0% year-over-year to $7313.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $7313.0 (down 50.0% YoY) and the FY2020 annual result came in at $14625.0, changed 0.0% from the prior year.
- Treasury Shares held at $7313.0 in Q3 2021 per IDYA's latest filing, from $7313.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $13.1 million in Q3 2018 and troughed at $7313.0 in Q1 2021.
- A 4-year average of $3.7 million and a median of $14625.0 in 2019 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2019 and 2020: Treasury Shares plunged 99.89% in 2019, then changed 0.0% in 2020.
- Over 4 years, Treasury Shares stood at $13.1 million in 2018, then slumped by 99.89% to $14625.0 in 2019, then changed by 0.0% to $14625.0 in 2020, then sank by 50.0% to $7313.0 in 2021.
- According to Business Quant data, Treasury Shares over the past three periods registered $7313.0, $7313.0, and $7313.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 2.72 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | IDEAYA Biosciences | 3.68 Bn | 2.85 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | 13.14 Mn |
| Mar 31, 2019 | 13.14 Mn |
| Dec 31, 2018 | 13.14 Mn |
| Dec 31, 2018 | 13.14 Mn |
| Sep 30, 2018 | 13.14 Mn |
| Sep 30, 2018 | 13.14 Mn |
| Jun 30, 2018 | 12.88 Mn |
| Jun 30, 2018 | 12.88 Mn |